. Presentation and . .. Sujet,

. .. Le-carcinome-hépatocellulaire,

L. 'imagerie-de-perfusion-hépatique and .. .. , 3.2. Bases théoriques du scanner de perfusion hépatique

. , Applications cliniques du scanner de perfusion hépatique

A. .. ,

S. .. ,

R. .. Bibliographiques,

R. Bibliographiques-?1?-european, Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer, J. Hepatol, vol.56, pp.908-943, 2012.

,

. ?2?-anon, Estimated cancer incidence, mortality and prevalence worldwide in, 2012.

A. Sangiovanni, G. M. Prati, P. Fasani, G. Ronchi, R. Romeo et al., The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients, Hepatology, vol.43, pp.1303-1310, 2006.

K. Okuda, Hepatocellular carcinoma: Recent progress, Hepatology, vol.15, pp.948-963, 1992.

,

M. Sakamoto, S. Hirohashi, and Y. Shimosato, Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma, Hum Pathol, vol.22, issue.2, p.1848205, 1991.

I. R. Wanless, Terminology of nodular hepatocellular lesions, Hepatology, vol.22, pp.983-993, 1995.

M. Borzio, S. Fargion, F. Borzio, A. L. Fracanzani, A. M. Croce et al., Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development, Journal of Hepatology, vol.39, pp.190-199, 2003.

Y. N. Park, C. P. Yang, G. J. Fernandez, O. Cubukcu, S. N. Thung et al., Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver, Am. J. Surg. Pathol, vol.22, pp.656-662, 1998.

H. A. Edmonson and P. E. Steiner, Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies, Cancer, vol.7, issue.3, pp.462-503, 1954.

?. F. Legou, F. Pigneur, S. Boussouar, L. Baranes, J. Chalaye et al., Imagerie du carcinome hépatocellulaire, EMC-RADIOLOGIE ET IMAGERIE MÉDICALE : AbdominaleDigestive, vol.9, issue.4, pp.1-20, 2014.

J. ?15?-bruix, M. Sherman, J. M. Llovet, M. Beaugrand, R. Lencioni et al., Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver, J. Hepatol, vol.35, pp.421-430, 2001.

J. Bruix and M. Sherman, Management of hepatocellular carcinoma, Hepatology, vol.42, pp.1208-1236, 2005.

J. ?17?-bruix and M. Sherman, American Association for the Study of Liver Diseases, Hepatology, vol.53, pp.1020-1022, 2011.

G. ?18?-cabibbo, M. Enea, M. Attanasio, J. Bruix, A. Craxì et al., A metaanalysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma, Hepatology, vol.51, pp.1274-1283, 2010.

K. Okuda, T. Ohtsuki, H. Obata, M. Tomimatsu, N. Okazaki et al., Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients, Cancer, vol.56, pp.918-928, 1985.

, ?20? The Cancer of the Liver Italian Program (CLIP) investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology, vol.28, pp.751-755, 1998.

S. Chevret, J. C. Trinchet, D. Mathieu, A. A. Rached, M. Beaugrand et al., Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma, J. Hepatol, vol.31, pp.133-141, 1999.

J. M. Llovet and J. Bruix, Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival, Hepatology, vol.37, pp.429-442, 2003.
DOI : 10.1053/jhep.2003.50047

URL : http://onlinelibrary.wiley.com/doi/10.1053/jhep.2003.50047/pdf

L. ?24?-marelli, R. Stigliano, C. Triantos, M. Senzolo, E. Cholongitas et al., Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies, Cardiovasc Intervent Radiol, vol.30, pp.6-25, 2007.

P. Therasse, S. G. Arbuck, E. A. Eisenhauer, J. Wanders, R. S. Kaplan et al., New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada, J. Natl. Cancer Inst, vol.92, pp.205-216, 2000.
DOI : 10.1007/bf02967383

M. ?30?-ronot, S. Lambert, J. Daire, M. Lagadec, S. Doblas et al., Can we justify not doing liver perfusion imaging in 2013?, Diagn Interv Imaging, vol.94, pp.1323-1336, 2013.

S. F. ?31?-halpin, Brain imaging using multislice CT: a personal perspective, Br J Radiol, 2004.

, , pp.20-26

E. Henderson, M. F. Milosevic, M. A. Haider, and I. W. Yeung, Functional CT imaging of prostate cancer, Phys Med Biol, vol.48, pp.3085-3100, 2003.

A. Chandler, W. Wei, E. F. Anderson, D. H. Herron, Z. Ye et al., Validation of motion correction techniques for liver CT perfusion studies, Br J Radiol, vol.85, pp.514-522, 2012.

V. ?34?-delmon,

. Imagerie-médicale and . Insa-de-lyon, , vol.?NNT, pp.2013-0128, 2013.

C. S. Ng, A. G. Chandler, W. Wei, E. F. Anderson, D. H. Herron et al., Effect of dual vascular input functions on CT perfusion parameter values and reproducibility in liver tumors and normal liver, J Comput Assist Tomogr, vol.36, pp.388-393, 2012.

T. ?36?-kanda, T. Yoshikawa, Y. Ohno, N. Kanata, H. Koyama et al., CT hepatic perfusion measurement: comparison of three analytic methods, Eur J Radiol, vol.81, pp.2075-2079, 2012.

C. S. ?37?-patlak, R. G. Blasberg, and J. D. Fenstermacher, Graphical evaluation of blood-tobrain transfer constants from multiple-time uptake data, J. Cereb. Blood Flow Metab, vol.3, pp.1-7, 1983.

S. ?38?-sourbron, Technical aspects of MR perfusion, Eur J Radiol, vol.76, pp.304-313, 2010.

,

E. ?39?-quaia, Assessment of tissue perfusion by contrast-enhanced ultrasound, Eur Radiol, vol.21, pp.604-615, 2011.

N. ?40?-kudomi, L. Slimani, M. J. Järvisalo, J. Kiss, R. Lautamäki et al., Non-invasive estimation of hepatic blood perfusion from H2 15O PET images using tissue-derived arterial and portal input functions, 2008.

, Eur. J. Nucl. Med. Mol. Imaging, vol.35, pp.1899-1911

D. Ippolito, C. Capraro, A. Casiraghi, C. Cestari, and S. Sironi, Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging, Eur Radiol, vol.22, pp.803-811, 2012.

D. Ippolito, S. Sironi, M. Pozzi, L. Antolini, L. Ratti et al., Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization, Acad Radiol, vol.15, pp.919-927, 2008.

H. F. Yang, Y. Du, J. X. Ni, X. P. Zhou, J. D. Li et al., Perfusion computed tomography evaluation of angiogenesis in liver cancer, Eur Radiol, vol.20, pp.1424-1430, 2010.

M. A. Fischer, N. Kartalis, A. Grigoriadis, L. Loizou, P. Stål et al., Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis, Eur Radiol, vol.25, pp.3123-3132, 2015.

L. Yang, X. Zhang, B. Tan, M. Liu, G. Dong et al., Computed tomographic perfusion imaging for the therapeutic response of chemoembolization for hepatocellular carcinoma, J Comput Assist Tomogr, vol.36, pp.226-230, 2012.

,

D. Ippolito, P. Bonaffini, L. Ratti, L. Antolini, R. Corso et al., Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusionCT in the assessment of residual tumor, World J. Gastroenterol, vol.16, pp.5993-6000, 2010.

H. P. Marquez, A. Karalli, H. Haubenreisser, R. P. Mathew, H. Alkadhi et al.,

T. Henzler and M. A. Fischer, Computed tomography perfusion imaging for monitoring transarterial chemoembolization of hepatocellular carcinoma, Eur J Radiol, vol.91, pp.160-167, 2017.

D. Ippolito, D. Fior, P. A. Bonaffini, C. Capraro, D. Leni et al., Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients, Eur J Radiol, vol.83, pp.1665-1671, 2014.

D. Ippolito, D. Fior, C. T. Franzesi, C. Capraro, A. Casiraghi et al., Tumour-related neoangiogenesis: functional dynamic perfusion computed tomography for diagnosis and treatment efficacy assessment in hepatocellular carcinoma, Dig Liver Dis, vol.46, pp.916-922, 2014.

F. Du, R. Jiang, M. Gu, C. He, and J. Guan, The clinical application of 320-detector row CT in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma, 2015.

, Radiol Med, vol.120, pp.690-694

S. Kaufmann, T. Horger, A. Oelker, S. Beck, M. Schulze et al.,

M. Horger, Volume perfusion computed tomography (VPCT)-based evaluation of response to TACE using two different sized drug eluting beads in patients with nonresectable hepatocellular carcinoma: Impact on tumor and liver parenchymal vascularisation, Eur J Radiol, vol.84, pp.2548-2554, 2015.

D. ?60?-tamandl, F. Waneck, W. Sieghart, S. Unterhumer, C. Kölblinger et al., Early response evaluation using CT-perfusion one day after transarterial chemoembolization for HCC predicts treatment response and long-term disease control, Eur J Radiol, vol.90, pp.73-80, 2017.

T. Wimmer, J. Steiner, E. Talakic, R. Stauber, F. Quehenberger et al., Computed Tomography Perfusion Following Transarterial Chemoembolization of Hepatocellular Carcinoma: A Feasibility Study in the Early Period, J Comput Assist Tomogr, vol.41, pp.708-712, 2017.

A. Sabir, R. Schor-bardach, C. J. Wilcox, S. Rahmanuddin, M. B. Atkins et al., Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy, AJR Am J Roentgenol, vol.191, pp.133-139, 2008.

R. ?63?-de-robertis, P. Tinazzi-martini, E. Demozzi, G. Puntel, S. Ortolani et al.,

A. Ruzzenente, A. Guglielmi, G. Tortora, C. Bassi, P. Pederzoli et al., Prognostication and response assessment in liver and pancreatic tumors: The new imaging, 2015.

, World J. Gastroenterol, vol.21, pp.6794-6808

H. B. El-serag, Epidemiology of viral hepatitis and hepatocellular carcinoma, 2012.

, Gastroenterology, vol.142, pp.1264-1273

J. K. ?65?-heimbach, L. M. Kulik, R. S. Finn, C. B. Sirlin, M. M. Abecassis et al., AASLD guidelines for the treatment of hepatocellular carcinoma, Hepatology, vol.67, pp.358-380, 2018.

V. ?66?-yaghmai, C. Besa, E. Kim, J. L. Gatlin, N. A. Siddiqui et al., Imaging assessment of hepatocellular carcinoma response to locoregional and systemic therapy, AJR Am J Roentgenol, vol.201, pp.80-96, 2013.

R. ?67?-garcía-figueiras, V. J. Goh, A. R. Padhani, S. Baleato-gonzález, M. Garrido et al., CT perfusion in oncologic imaging: a useful tool?, AJR Am J Roentgenol, vol.200, pp.8-19, 2013.

T. Jiang, A. Kambadakone, N. M. Kulkarni, A. X. Zhu, and D. V. Sahani, Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, 2012.
DOI : 10.1097/rli.0b013e3182199bb5

, Invest Radiol, vol.47, pp.11-17

S. Kaufmann, W. M. Thaiss, M. Schulze, M. Bitzer, U. Lauer et al., Prognostic value of perfusion CT in hepatocellular carcinoma treatment with sorafenib: comparison with mRECIST in longitudinal follow-up, Acta Radiol, 2017.

L. ?70?-lladó, J. Virgili, J. Figueras, C. Valls, J. Dominguez et al., A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization, Cancer, vol.88, pp.50-57, 2000.

S. Ogasawara, T. Chiba, Y. Ooka, N. Kanogawa, T. Motoyama et al., A prognostic score for patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization, PLoS ONE, vol.10, 2015.
DOI : 10.1371/journal.pone.0125244

URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0125244&type=printable

M. ?72?-lin, M. Tian, W. Zhang, L. Xu, and P. Jin, Predictive values of diffusionweighted imaging and perfusion-weighted imaging in evaluating the efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma, Onco Targets Ther, vol.9, pp.7029-7037, 2016.

S. ?73?-takaki, H. Sakaguchi, H. Anai, T. Tanaka, K. Yamamoto et al., Long-term outcome of transcatheter subsegmental and segmental arterial chemoemobolization using lipiodol for hepatocellular carcinoma, Cardiovasc Intervent Radiol, vol.35, pp.544-554, 2012.

K. Ikeda, H. Kumada, S. Saitoh, Y. Arase, and K. Chayama, Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model, Cancer, vol.68, pp.2150-2154, 1991.

R. Kloeckner, G. Otto, S. Biesterfeld, K. Oberholzer, C. Dueber et al., MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma, Cardiovasc Intervent Radiol, vol.33, pp.532-540, 2010.

R. Syha, G. Grözinger, U. Grosse, M. Maurer, L. Zender et al., Parenchymal Blood Volume Assessed by C-Arm-Based Computed Tomography in Immediate Posttreatment Evaluation of Drug-Eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma, Invest Radiol, vol.51, pp.121-126, 2016.

N. ?77?-rathmann, K. Kara, J. Budjan, T. Henzler, A. Smakic et al., Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization, 2017.

, Anticancer Res, vol.37, pp.5681-5685

L. Yang, X. M. Zhang, X. P. Zhou, W. Tang, Y. S. Guan et al., Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization, J Vasc Interv Radiol, vol.21, pp.1841-1846, 2010.
DOI : 10.1016/j.jvir.2010.08.015

T. Su, W. He, L. Jin, G. Chen, and G. Xiao, Early Response of Hepatocellular Carcinoma to Chemoembolization: Volume Computed Tomography Liver Perfusion Imaging as a Short-Term Response Predictor, J Comput Assist Tomogr, vol.41, pp.315-320, 2017.

,. ?80?-bai, J. Li, S. Ren, H. Jiang, X. Liu et al., A correlation of computed tomography perfusion and histopathology in tumor edges of hepatocellular carcinoma, HBPD INT, vol.13, pp.612-617, 2014.

D. V. Sahani, N. Holalkere, P. R. Mueller, and A. X. Zhu, Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue-initial experience, Radiology, vol.243, pp.736-743, 2007.

S. N. Martins-filho, C. Paiva, R. S. Azevedo, and V. A. Alves, Histological Grading of, 2017.

, Hepatocellular Carcinoma-A Systematic Review of Literature